glp-1 agonist and pancreatitis New data links agonists for weight loss with higher risk for pancreatitis, GI events GLP-1 Receptor Agonists | New
Description
No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes
Severe, prolonged thrombocytopenia in a patient sensitive to exenatide
Saunders: References (20) National Institute of Mental Health
doi: 10.7334/psicothema2015.244
10.7759/cureus.38263 45 JeyarajS.ShettyA
